Practice and safety of allergen‐specific immunotherapy for allergic rhinitis in the UK national health service: A report of “real world” clinical practice

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2222|48|1|89-92

ISSN： 0954-7894

Source： CLINICAL & EXPERIMENTAL ALLERGY, Vol.48, Iss.1, 2018-01, pp. : 89-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Allergen‐specific basophil reactivity exhibits daily variations in seasonal allergic rhinitis

By  

ALLERGY, Vol. 70, Iss. 3, 2015-03 ,pp. : 319-322

John Wiley & Sons Inc

Access to resources Recommend Favorite

Improvement and prevention of asthma with concomitant treatment of allergic rhinitis and allergen‐specific therapy

By  

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, Vol. 5, Iss. S1, 2015-09 ,pp. : S45-S50

John Wiley & Sons Inc

Access to resources Recommend Favorite

National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE‐II

By  

ALLERGY, Vol. 73, Iss. 3, 2018-03 ,pp. : 664-672

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Studies in Oral Allergen-Specific Immunotherapy: Differences among Allergens

By  

International Archives of Allergy and Immunology, Vol. 164, Iss. 1, 2014-04 ,pp. : 1-9

Karger

Access to resources Recommend Favorite

The Safety of Allergen Specific Sublingual Immunotherapy

By  

Current Drug Safety, Vol. 2, Iss. 2, 2007-05 ,pp. : 117-123

Bentham Science Publishers

Access to resources Recommend Favorite